Hopp til hovedinnhold

Nærsynthet

Sist revidert:
Sist revidert av:
Definisjon:
Ved nærsynthet fokuseres fjerne objekter foran retina i uakkomodert øye
Forekomst:
Prevalens globalt er økende. I Norge ca. 35%
Symptomer:
Nedsatt avstandssyn
Funn:
Nedsatt visus
Diagnostikk:
Adekvat refraksjonsundersøkelse hos optiker nødvendig for diagnose og behandling
Behandling:
Brillekorreksjon, kontaktlinser, intraokulære linser eller utskiftning av de naturlige linsene med kunstige
  1. Flitcroft DI, He M, Jonas JB, et al. IMI - Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies. Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M20-M30. PMID: 30817826 PubMed  
  2. Li SM, Li SY, Liu LR, et al. Peripheral refraction in 7- and 14-year-old children in central China: the Anyang Childhood Eye Study. Br J Ophthalmol 2015; 99:674 British Journal of Ophthalmology  
  3. Midelfart A, Kinge B, Midelfart S, Lydersen S. Prevalens av brytningsfeil i Norge. Tidsskr Nor Lægeforen 2004; 124: 46-8. PubMed  
  4. Saw S-M, Matsumura S, Hoang QV. Prevention and management of myopia and myopic pathology. Investigative Ophthalmology & Visual Science February 2019; 60: 488-499. PMID: 30707221 PubMed  
  5. Lee KE, Klein BEK, Klein R, Wong TY. Changes in refraction over 10 Years in an adult population: The Beaver Dam Eye Study. Invest Ophthalmol Vis Sci 2002; 43: 2566 - 71. PubMed  
  6. Cordain L, Eaton SB, Miller JB, Lindeberg S, Jensen C. An evolutionary analysis of the aetiology and pathogenesis of juvenile-onset myopia. Acta Ophthalmol Scand 2002; 80: 125 - 35. PubMed  
  7. Saw S-M, Wu H-M, Seet B, Wong T-Y, Yap E, Chia K-S et al. Academic achievement, close up work parameters, and myopia in Singapore military conscripts. Br J Ophthalmol 2001; 85: 855 - 60. British Journal of Ophthalmology  
  8. Taravella M. LASIK myopia. Medscape, last updated Dec 03, 2018. emedicine.medscape.com  
  9. Kuryan J, Cheema A, Chuck RS. Laser‐assisted subepithelial keratectomy (LASEK) versus laser‐assisted in‐situ keratomileusis (LASIK) for correcting myopia. Cochrane Database of Systematic Reviews 2017, Issue 2. Art. No.: CD011080. DOI: 10.1002/14651858.CD011080.pub2. Accessed 14 September 2022. The Cochrane Library  
  10. Alio JL, Muftuoglu O, Ortiz D, et al. Ten-year follow-up of laser in situ keratomileusis for myopia of up to -10 diopters. Am J Ophthalmol 2008; 145: 46-54. PubMed  
  11. Eydelman M, Hilmantel G, Tarver ME, et al. Symptoms and Satisfaction of Patients in the Patient-Reported Outcomes With Laser In Situ Keratomileusis (PROWL) Studies. JAMA Ophthalmol. 2017;135(1):13-22. PubMed  
  12. Wilkinson JM, Cozine EW, Kahn AR. Refractive Eye Surgery: Helping Patients Make Informed Decisions About LASIK. Am Fam Physician. 2017;95(10):637-644. PubMed  
  13. Barsam A, Allan BD. Excimer laser refractive surgery versus phakic intraocular lenses for the correction of moderate to high myopia. Cochrane Database Syst Rev. 2014 ;6:CD007679. DOI: 10.1002/14651858.CD007679.pub4. DOI  
  14. Cooper J, Tkatchenko AV. A review of current concepts of the etiology and treatment of myopia. Eye Contact Lens. 2018;44(4):231-247. PubMed  
  15. Yam JC, Jiang Y, Tang SM, et al. Low-Concentration Atropine for Myopia Progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control. Low-concentration Atropine for Myopia Progression. Ophthalmology. 2018 Jul 6.
  16. Walline JJ, Lindsley KB, Vedula SS, et al. Interventions to slow progression of myopia in children. Cochrane Database of Systematic Reviews 2020, Issue 1. Art. No.: CD004916. DOI: 10.1002/14651858.CD004916.pub4. Accessed 14 September 2022. The Cochrane Library  
  17. Chia A, Lu Q-S, Tan D. Five-Year Clinical trial on atropine for the treatment of myopia 2. Ophtalmology, published online Aug 11 2015. doi:http://dx.doi.org/10.1016/j.ophtha.2015.07.004
  • Terje Johannessen, professor i allmennmedisin, Trondheim

Tidligere fagmedarbeidere

  • Johan H. Seland, professor emeritus, Universitetet i Bergen
  • Knut A. Holtedahl, professor i allmennmedisin, Institutt for samfunnsmedisinske fag, Universitetet i Tromsø